Oculus Innovative Sciences to Announce Fiscal Third Quarter 2007 Results on Wednesday, February 21

To Present at Roth Conference February 21


Oculus Innovative Sciences, Inc. (Nasdaq: OCLS) announced that it will release financial results for its third fiscal quarter ended December 31, 2006, on February 21, 2007 before market open.

The Company will present at the Roth Capital Partners Annual OC Conference in Dana Point, California on February 21 at 9:30 am Pacific Time. Hoji Alimi, president and chief executive officer, will discuss the Company and most recent quarter during that presentation which will be web cast.

To access a live audio webcast of Mr. Alimi's presentation, please log on to Oculus Innovative Sciences' website at http://www.oculusis.com approximately 15 minutes prior to the presentation in order to register and download any necessary software. A replay of the audio presentation will be available on the web site for approximately 90 days following the presentation.

About Oculus

Oculus Innovative Sciences, Inc. is a medical technology company focused on the development, manufacture and marketing of a family of products intended to help prevent and treat infection in acute and chronic wounds. Oculus' products based on its Microcyn Technology have received CE Mark, or European Union certification, for wound cleaning and reduction of microbial load, three U.S. FDA 510(k) clearances as a medical device in wound cleaning, lubricating, moistening and dressing, and has been granted additional approvals in Canada, India and Mexico.

Oculus' principal operations are in Petaluma, California, and it conducts operations in Europe and Latin America through its wholly owned subsidiaries, Oculus Innovative Sciences Netherlands B.V. and Oculus Technologies of Mexico, S.A. de C.V. Our website is www.oculusis.com.

Source: Oculus Innovative Sciences, Inc.